Breakout Companies Power Our Future
- REACH INDUSTRIESBuilding the visual intelligence layer for regulated environments
- PHANTOM NEUROBringing natural control to robotic systems with AI
- STEALTH COAutomating chemical analysis to accelerate drug discovery and development
- EPANA BIOAdvancing autoimmune care with precision therapies
- COPERNIC CATALYSTSDesigning chemical catalysts using physics-based computation
- NOETIKTraining foundation models for human biology
- STEALTH COAI-enabled reproducibility infrastructure to unlock commercial distribution of scientific innovations
- ENPLUSONE BIOHarnessing enzymes to produce RNA-based therapeutics
- CYTOVALECombining hardware and AI to diagnose sepsis in real time
- IMMUSOFTEngineering B cells to produce therapeutics within the body
- VITRA LABSReimagining the future of fertility with hormone-free IVF
- ZYMOCHEMIncreasing performance chemical yields with biomanufacturing
- A-ALPHA BIODiscovering drugs through millions of protein-protein interactions
- PASSKEY THERAPEUTICSUncovering multifunctional drugs with advanced computation
- GENERAL SENSEDecoding chemical signatures into sensory reasoning models
- SURF BIO • EXITEDStabilizing biologics to address drug delivery’s core challenge *Acquired by Halozyme (HALO)*
- TWELVETransforming carbon dioxide emissions into useful chemicals
- PARALLEL BIOPutting the immune system in a dish to improve drug discovery
- CHECKERSPOTProducing hard-to-source fats and oils with microalgae
- INCENDIA THERAPEUTICSReprogramming the tumor microenvironment to eliminate cancer
- SHIRATRONICSDefeating migraines using minimally invasive neuromodulation
- CELLCHORUSInvestigating single-cell interactions to improve cell therapies
- TFC THERAPEUTICSFinding new therapeutic routes to stop cancer for good
- ECOVATIVE DESIGNDriving plant-based meats and textiles with mycelium
- MODERN MEADOWInnovating materials with bio-design technology
- STRM.BIOHarnessing extracellular vesicles to deliver gene therapies in-vivo
- CORTEXYME • EXITEDNovel therapeutic approach to treating underlying causes of neurodegenerative diseases *IPO 2019*